Quest Diagnostics Incorporated (NYSE:DGX) on Tuesday reported first-quarter adjusted earnings of $2.50 per share, beating the consensus of $2.35.
Quest Diagnostics Reports Strong Organic Growth
The provider of diagnostic information services reported sales of $2.895 billion, up 9.2% year over year, beating the consensus of $2.827 billion. Consolidated organic revenues grew by 9%.
Operating income increased 15.5% to $399 million. Adjusted operating income was $447 million, or a margin of 15.4%, compared to $406 million, or 15.3% of revenues, last year.
Volume Growth Driven By Partnerships, Core Demand
Total volume, measured by the number of requisitions, increased 10.9% versus the first quarter of 2025, with organic …